Pregledni rad
Kidney Transplantation in High Immunological Risk Recipients
Bojana Maksimović
Puni tekst: hrvatski pdf 87 Kb
str. 213-218
preuzimanja: 39
citiraj
APA 6th Edition
Maksimović, B. (2023). Kidney Transplantation in High Immunological Risk Recipients. Medicus, 32 (2. Transplantacija), 213-213. Preuzeto s https://hrcak.srce.hr/index.php/315860
MLA 8th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus, vol. 32, br. 2. Transplantacija, 2023, str. 213-213. https://hrcak.srce.hr/index.php/315860. Citirano 22.05.2024.
Chicago 17th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus 32, br. 2. Transplantacija (2023): 213-213. https://hrcak.srce.hr/index.php/315860
Harvard
Maksimović, B. (2023). 'Kidney Transplantation in High Immunological Risk Recipients', Medicus, 32(2. Transplantacija), str. 213-213. Preuzeto s: https://hrcak.srce.hr/index.php/315860 (Datum pristupa: 22.05.2024.)
Vancouver
Maksimović B. Kidney Transplantation in High Immunological Risk Recipients. Medicus [Internet]. 2023 [pristupljeno 22.05.2024.];32(2. Transplantacija):213-213. Dostupno na: https://hrcak.srce.hr/index.php/315860
IEEE
B. Maksimović, "Kidney Transplantation in High Immunological Risk Recipients", Medicus, vol.32, br. 2. Transplantacija, str. 213-213, 2023. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/315860. [Citirano: 22.05.2024.]
Puni tekst: engleski pdf 87 Kb
str. 213-213
preuzimanja: 21
citiraj
APA 6th Edition
Maksimović, B. (2023). Kidney Transplantation in High Immunological Risk Recipients. Medicus, 32 (2. Transplantacija), 213-213. Preuzeto s https://hrcak.srce.hr/index.php/315860
MLA 8th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus, vol. 32, br. 2. Transplantacija, 2023, str. 213-213. https://hrcak.srce.hr/index.php/315860. Citirano 22.05.2024.
Chicago 17th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus 32, br. 2. Transplantacija (2023): 213-213. https://hrcak.srce.hr/index.php/315860
Harvard
Maksimović, B. (2023). 'Kidney Transplantation in High Immunological Risk Recipients', Medicus, 32(2. Transplantacija), str. 213-213. Preuzeto s: https://hrcak.srce.hr/index.php/315860 (Datum pristupa: 22.05.2024.)
Vancouver
Maksimović B. Kidney Transplantation in High Immunological Risk Recipients. Medicus [Internet]. 2023 [pristupljeno 22.05.2024.];32(2. Transplantacija):213-213. Dostupno na: https://hrcak.srce.hr/index.php/315860
IEEE
B. Maksimović, "Kidney Transplantation in High Immunological Risk Recipients", Medicus, vol.32, br. 2. Transplantacija, str. 213-213, 2023. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/315860. [Citirano: 22.05.2024.]
Sažetak
HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. It often leads to prolonged waiting time on transplant lists and significantly increased morbidity and mortality. Over the last decade new technologies of HLA antibody identification have emerged, as well as several immunomodulatory therapies allowing for increased access to kidney transplantation for the immunologically disadvantaged group of HLA sensitized end-stage kidney disease patients. Also, a different allocation program was introduced in order to prioritize these groups of patients. Still there is an unmet need for more efficient and safer therapies to avoid HLA sensitization. The collaboration of transplant physicians, immunologists, and pharmaceutical industries is crucial to delineate a path forward to improve access to kidney transplantation.
Ključne riječi
kidney transplantation; HLA sensitization; HLA antibodies
Hrčak ID:
315860
URI
https://hrcak.srce.hr/315860
Datum izdavanja:
9.4.2024.
Podaci na drugim jezicima:
hrvatski
Posjeta: 116
*
